drugset / Trial / NCT02818738

Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children

NCT02818738

Phase 3 Completed 86 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupDouble-blindTreatment

Summary

Idiopathic Nephrotic Syndrome is sensitive to steroid in 90% of children. However, most patients relapse and become steroid-dependant, with a long lasting relapsing course. The aim of this study is to assess the efficiency of a 6-months levamisole course, given early after first remission, on maintaining a relapse-free course at 12 months.

Timeline

Start
2017-09-06
Primary completion
2021-02-07
Completion
2021-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levamisole Small molecule 2.5 mg/kg Oral